The coronavirus pandemic has killed at least 1,972,707 people worldwide since the appearance of the very first carrier cases in China in December 2019.
The total number of cases having contracted the virus has reached 92,122,678 people worldwide of which 24,181,691 are considered active cases while 65,968,280 are considered recovered from the disease. In addition, a total of 29,427,452 people have already been vaccinated worldwide.
The United States is the country most affected with 380,821 deaths. Brazil follows with 204,690 dead, India (151,569), Mexico (135,682) and the United Kingdom (83,203).
Jordan launched its coronavirus vaccination campaign on Wednesday, starting with healthcare workers, people with chronic diseases and those over the age of 60. The country is targeting the vaccination of 10 million inhabitants and promises a completely free vaccine for Jordanians and foreign residents.
Jordan on Saturday granted an “emergency license” to use Sinopharm’s Chinese vaccine, the second vaccine to be approved in Jordan after Pfizer-BioNTech’s American-German.
For its part, Japan, which has just detected a new Brazilian variant of the coronavirus, is seeking to contain its spread. The new variant has been detected in four people from Brazil.
This variant of SARS-CoV-2 results from an evolution of “a viral line from Brazil, which circulates in the Amazon”, provisionally called “B.1.1.28 (K417N / E484K / N501Y)”, affirmed the Brazilian researcher. Felipe Naveca, who collaborates with the Fiocruz Institute.
“The results suggest that the mutation detected in the B.1.1.28 variant is a recent phenomenon, probably occurring between December 2020 and January 2021”, the institute said in a press release.
Ecuador announced that it had recorded three new cases of British variant covid-19 infection by the time Patient Zero, a 50-year-old man returning from a trip to the UK, arrived in the country with a negative certificate. The toll of people with this new variant rose to 4 people.
The Institute of Microbiology of the Free University of San Francisco in Quito analyzed six biological samples taken from relatives of the first patient infected with this variant of the virus, and three of them tested positive, said Veronica Barragan, researcher with this institute.